You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

177lutetium-DOTA(O)Tyr3)octreotate

Showing 1 - 25 of 809
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Metastatic Neuroendocrine Tumor Trial (Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate)

Not yet recruiting
  • Metastatic Neuroendocrine Tumor
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Feb 10, 2023

Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma Trial in Rochester (radiation, drug, procedure, other)

Recruiting
  • Grade 1 Meningioma
  • +4 more
  • Gallium Ga 68-DOTATATE
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

Not yet recruiting
  • Neuroblastoma
  • PRRT with 177Lu-DOTATATE
  • Lille, France
  • +2 more
Nov 8, 2022

Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

Active, not recruiting
  • Neuroendocrine Carcinoma
  • Lu-DOTA-TATE
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 5, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • +4 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jan 14, 2023

Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

Recruiting
  • Neuroendocrine Neoplasm
  • Biospecimen Collection
  • +4 more
  • Duarte, California
  • +3 more
Jan 12, 2023

Metastatic Digestive System Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in United States (Lutetium Lu 177

Recruiting
  • Metastatic Digestive System Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Tumor
  • Phoenix, Arizona
  • +10 more
Aug 23, 2022

Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

Suspended
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Sep 21, 2022

Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutetium[177Lu] Oxodotreotide Injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 30, 2023

Carcinoma, Neuroendocrine Trial in Edmonton ([177]Lu-DOTA-TATE)

Recruiting
  • Carcinoma, Neuroendocrine
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Apr 12, 2021

Lutathera® in Somatostatin Receptor Positive

Recruiting
  • Somatostatin Receptor-positive GEP-NET
  • Lutathera
  • Seongnam Si, Gyeonggi Do, Korea, Republic of
  • +4 more
Jun 29, 2022

Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,

Recruiting
  • Ganglioneuroblastoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Small Cell Lung Cancer, Small Cell Lung Cancer Extensive Stage Trial in Washington, Hackensack (Nivolumab,

Completed
Has Results
  • Small Cell Lung Cancer
  • Small Cell Lung Cancer Extensive Stage
  • Washington, District of Columbia
  • +1 more
Feb 22, 2021

Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)

Completed
Has Results
  • Carcinoid Tumor of the Small Bowel
  • Neuroendocrine Tumour
  • Los Angeles, California
  • +38 more
Mar 10, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Neuroendocrine Tumors Trial in China (Lutetium[177Lu] Oxodotreotide Injection, Octreotide LAR)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutetium[177Lu] Oxodotreotide Injection
  • Octreotide LAR
  • Beijing, Beijing, China
  • +20 more
Jul 25, 2022

Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

Recruiting
  • Meningioma
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2022

Dosimetry Trial in Vandoeuvre/les/nancy (Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT))

Recruiting
  • Dosimetry
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • Vandoeuvre/les/nancy, France
    Chru Nancy
Aug 3, 2021

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • CT (Computed Tomography)
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 3, 2022

Neuroendocrine Tumors Trial in Warszawa (90Y-DOTATATE, (177Lu-DOTAOTyr3)Octreotate, 90Y DOTATATE and 177Lu DOTATATE (mix each of

Unknown status
  • Neuroendocrine Tumors
  • Warszawa, Poland
    Centrum Diagnostyczno-Lecznicze Gammed
Mar 31, 2020

Neuroendocrine Tumors, Carcinoid Tumor, Carcinoma, Neuroendocrine Trial in Quebec City (177Lu-Octreotate)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Quebec City, Quebec, Canada
    CHU de Québec - Université Laval
Jul 15, 2020

Neuroendocrine Tumors Trial in Edmonton ([68]Ga-HA-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jun 18, 2021